Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Interim three-month data for ISA-247 kidney transplant trial

May 10, 2007

New data indicate Homspera may demonstrate adjuvant capabilities

May 10, 2007

GenVec obtains additional funding for malaria vaccine program

May 8, 2007

VGX signs DNA vaccines license agreement with U. of Pennsylvania

May 2, 2007

Advagraf receives E.U. approval

April 30, 2007

Novel treatments for immunological diseases claimed in recent patent literature

April 30, 2007

Allergy Therapeutics reports promising results of oral allergy vaccine study

April 24, 2007

GenPhar's novel dengue virus vaccine active against all virus serotypes

April 24, 2007

Pevion and Mymetics sign virosome technology license agreement

April 18, 2007

ACE and NMRC begin Campylobacter challenge study

April 18, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...